Sanofi Consumer Healthcare India Ltd. Company History and Annual Growth Details

The Company was incorporated as a public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated May 10, 2023, issued by the Registrar of Companies, Central Registration Centre.Â

Major Events and Milestones:

2023Â

Incorporation of the Company

2024Â

Demerger, transfer and vesting of the Demerged Undertaking from Sanofi India Limited into theÂ Company on a going concern basis pursuant to the SchemeÂ

2020
-Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030.

2021
-Sanofi completed acquisition of Kadmon.
-Sanofi completed acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics.
-Sanofi launched its new global employee share ownership plan.
-Sanofi established three-year collaboration with Stanford Medicine to accelerate immunology research.

2022
-Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology.
-Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine.
-Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth.
-Sanofi recognized by S&P as one of the most sustainability- committed companies.
-Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board.

2023
-SanofiÂs Consumer Healthcare Unit launches the Shared Care Collective, an advisory group working to advance sustainability.
-Sanofi completes acquisition of Qunol.
-Sanofi completes acquisition of Provention Bio, Inc.
- Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care.

2024
-Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline.

2025

-SanofiÂs breakthrough therapy RezurockÂ® approved in India for treating patients living with chronic graft-versus-host disease.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article